Biopharmaceutical Services
April Biopharmaceutical Services Newsletter
Quick Links
Upcoming Events
Meet Our Experts
Facility Highlight
Upcoming Events

IBC 22nd Biological Assays: Development, Validation and Maintenance 
Boston, MA
April 30 - May 4, 2012

PDA/FDA Viral and TSE Safety Conference
Bethesda, MD
May 15-17, 2012

BIO International Convention
Boston, MA
June 18-21, 2012
July 4-5, 2012

Click here to see additional events or contact us at to learn more.
Meet Our Experts       


Dr. Michael Hantman is the Associate Director of Methods Development at our Malvern, Pennsylvania site. Over the past 10 years, Dr. Hantman and his team have developed a portfolio of over 70 assays and methods to offer our clients, focusing primarily on nucleic acid amplification technologies. They have been responsible for over 35 new assay validations and qualifications in the last four years, including quantitative fluorescent PCR assays for adventitious agents, residual DNA assays, copy number assays and nucleic acid sequencing projects.


Mr. Zane Honnold is the Director of Global Sales for Biopharmaceutical Services. He received his B.Sc. in Biochemistry/Chemistry from North Carolina State University. He has 17+ years experience in contract pharmaceutical development services and sales.


Zane can be contacted at

Charles River Laboratories International, Incorporated

251 Ballardvale St.
Wilmington, MA  01887
Expanding Our Offerings Through New Industry Partners
At Charles River, our goal is to provide clients with a wide range of services that meet their regulatory and scientific needs. The following partnerships enhance our ability to exceed client expectations by offering cost-effective, innovative solutions that accelerate the production and safety assessment of biopharmaceutical products.
It was recently announced that EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, will be partnering with Charles River to exclusively license EMD Millipore's TrueSpike™ technology. EMD Millipore and Charles River will collaborate to integrate the TrueSpike™ technology into client-specified viral clearance projects provided by Charles River, which is designed to result in a more predictable and consistent study outcome for clients, and ultimately help to improve drug product safety. Learn more.
Charles River and Protagen AG, a GMP-certified specialist in the characterization of protein drugs, recently announced a strategic partnership.  
Our partnership with Protagen AG will provide clients with services covering the entire range of protein analytics, from detailed protein characterization to stability and lot release testing. Learn more.



GENEWIZ, Inc. is a leading global contract research organization that offers DNA sequencing, gene synthesis, molecular biology, genomic, GLP regulatory and bioinformatics services. 


Clients will benefit from this partnership by receiving Charles River's expertise and experience in cell and viral bank characterization with the added option of GENEWIZ's industry-leading Next Generation Sequencing services. Learn more.

Facility Highlight


Ballina Facility Expands for Challenge Studies


Biopharmaceutical Services (BPS) Ireland Facility Expands, Offering More Capacity and Improved Timelines for Challenge Studies and Effective Vaccine Development

At our Charles River Ballina, Ireland facility, we now offer additional BSL-2 containment for clients working in vaccine development.

What does the BPS Ireland facility expansion at Ballina mean to you and your research programs? Click here to learn more and to view a video about the new facility.